Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects

Effect of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms on Susceptibility to Type 2 Diabetes in Malaysian Subjects

Elevated activity of plasminogen activator inhibitor-1 (PAI-1) and decreased tissue plasminogen activator (tPA) activity are considered to be important risk factors for type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS). The aim of this study was to investigate the association of the PAI-...

Full description

Bibliographic Details
Main Authors:	Zaid Al-Hamodi, Riyadh Saif-Ali, Ikram S. Ismail, Khaled A. Ahmed, Sekaran Muniandy
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	Journal of Biomedicine and Biotechnology
Online Access:	http://dx.doi.org/10.1155/2012/234937

Similar Items

Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
by: Saif-Ali Riyadh, et al.
Published: (2011-03-01)

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
by: Yu Zuo, et al.
Published: (2021-01-01)

Structural basis of specific inhibition of tissue-type plasminogen activator by plasminogen activators inhibitor-1
by: Lihu Gong, et al.
Published: (2016-03-01)

The study of the expression of plasminogen activator and plasminogen activator inhibitor in radicular cysts
by: Weng, Sheng-Feng, et al.
Published: (2004)

IGF2BP2 alternative variants associated with glutamic acid decarboxylase antibodies negative diabetes in Malaysian subjects.
by: Sameer D Salem, et al.
Published: (2012-01-01)

Tissue plasminogen activator and plasminogen activator inhibitor 1 contribute to sonic hedgehog-induced in vitro cerebral angiogenesis.
by: Hua Teng, et al.
Published: (2012-01-01)

THE LEVELS OF PLASMINOGEN AND INHIBITOR OF PLASMINOGEN ACTIVATORS OF TYPE 1 IN ANTIPHOSPHOLIPID SYNDROME
by: E V Ostryakova, et al.
Published: (2012-05-01)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
by: Kamlesh K. Gupta, et al.
Published: (2017-03-01)

Association of plasminogen activator inhibitor gene polymorphism of endometrial cancer
by: Chung-Kuang, et al.
Published: (2012)

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators
by: M. Akrami, et al.
Published: (2006-07-01)

Plasminogen activator inhibitor-1 in endometriosis
by: Alotaibi, Fahad T
Published: (2016)

The effect of the environment on plasminogen activators and inhibitors
by: Woods, Alison J.
Published: (1998)

Fibrinolysis regulation by platelets retaining plasminogen and tissue-type plasminogen activator on their surface
by: T. Grinenko, et al.
Published: (2019-12-01)

The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.
by: Marlien Pieters, et al.
Published: (2017-01-01)

Genetic variation at the plasminogen activator inhibitor-1 locus and its effect on plasminogen activator inhibitor-1 expression
by: Dawson, Sally
Published: (1991)

KCNQ1 Haplotypes Associate with Type 2 Diabetes in Malaysian Chinese Subjects
by: Aied M. Alabsi, et al.
Published: (2011-09-01)

Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor Induction by Etoposide in a Glioblastoma Cell Strain
by: Branko Brdar, et al.
Published: (2002-01-01)

Retraction: The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.
by: PLOS ONE Editors
Published: (2018-01-01)

Characterization of plasmin, plasminogen and plasminogen activator in goat milk
by: F. Polidori, et al.
Published: (2011-03-01)

Roles of tissue plasminogen activator and its inhibitor in proliferative diabetic retinopathy
by: Shu-Ling Wu, et al.
Published: (2014-10-01)

Plasminogen activator inhibitor-1 in the evolution of stroke
by: Jovanović Zagorka B., et al.
Published: (2004-01-01)

Functional Stability of Plasminogen Activator Inhibitor-1
by: Songul Yasar Yildiz, et al.
Published: (2014-01-01)

Tissue plasminogen activator mediates deleterious complement cascade activation in stroke.
by: Xue-Jun Zhao, et al.
Published: (2017-01-01)

Intravitreal tissue plasminogen activator in submacular haemorrhage
by: Singh Preetam, et al.
Published: (1999-01-01)

The hormonal control of plasminogen activation in gonadal tissues
by: Coombs, R. J.
Published: (1988)

The Chemistry of the Activation of Plasminogen
by: Cederholm-Williams, Stewart A.
Published: (1977)

Prothrombin and plasminogen activation
by: Douglas, Alexander Stuart
Published: (1975)

Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients.
by: Sebastian Zukowski, et al.
Published: (2008-06-01)

Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
by: Gregory Imbarrato, et al.
Published: (2018-04-01)

Plasminogen Activator Inhibitor-1 and the Insulin Resistance Syndrome
by: Byberg, Liisa
Published: (2002)

Does plasminogen activator inhibitor-1 drive lymphangiogenesis?
by: Françoise Bruyère, et al.
Published: (2010-01-01)

Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome
by: T M Reshetniak, et al.
Published: (2013-01-01)

Polymorphism in methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and apolipoprotein E in hemodialysis patients
by: Al-Muhanna Fahad, et al.
Published: (2008-01-01)

Plasminogen polymorphism in dairy cattle
by: Wang, Wei
Published: (1994)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
by: Witzel I, et al.
Published: (2014-11-01)

Role of Osteopontin, Vascular Endotheliol Growth Factor, Urokinase-type Plasminogen Activator and Plasminogen Activator Inhibitor in Malignant Pleural Effusions
by: Pei-Chi Hsu, et al.
Published: (2012)

Studies on the regulation of tissue plasminogen activator activity by physiological templates
by: Williams, Stella Claire
Published: (2012)

Drug Dependence, Synaptic Plasticity, and Tissue Plasminogen Activator
by: Kiyofumi Yamada, et al.
Published: (2005-01-01)

Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
by: Nancy Kunjukunju, et al.
Published: (2011-02-01)

Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
by: Yasuhiro Suzuki
Published: (2010-01-01)